Healthcare

Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.

Bharat's Covid shot shows high immune response, further study needed for elderly

Healthcare

09 March, 2021

Bharat's Covid shot shows high immune response, further study needed for elderly

A COVID-19 vaccine developed by India's Bharat Biotech is safe and has shown high levels of antibody response in a ......

Premium

Healthcare

09 March, 2021

Belgian impact investor to take reins of IL&FS PE fund

A Belgian impact investor with healthcare bets in India is set to take over the management of IL&FS’s only operational...

Healthcare

03 March, 2021

Bharat Biotech says Covid vaccine shows 81% interim efficacy

Bharat Biotech's homegrown Covid-19 vaccine has shown an interim vaccine efficacy of 81% in late-stage clinical trials, the...

Premium

Healthcare

03 March, 2021

Market-bound healthcare chain looks to buy hospital turned around by PE

Ahead of its IPO, KIMS is trying to buy a Bengaluru hospital on the cheap, which turned around under a ......

Healthcare

03 March, 2021

UK to get 10 mn AstraZeneca Covid vaccine doses from Serum Institute

The UK will receive 10 million AstraZeneca Covid-19 vaccine doses made by the Serum Institute of India (SII), the UK ......

Premium

Healthcare

02 March, 2021

Steadview pares API maker stake in third exit in a month

In its third exit from an Indian portfolio company within a month, Asia focussed hedge fund Steadview Capital has sold ......

Premium

Healthcare

02 March, 2021

Tano Capital backed Windlas ropes in bankers for IPO

Tano Capital backed pharmaceuticals company Windlas Biotech Pvt. Ltd has signed up investment bankers for its public float, two...

Healthcare

02 March, 2021

Healthcare investor OrbiMed raises Asia private equity fund, overshoots target

Healthcare investment firm OrbiMed has raised its fourth Asia private equity fund primarily focused on China and India, overshooting...

Healthcare

02 March, 2021

J&J working to bring very high capacity plant in India: Exec

Johnson & Johnson is waiting on regulatory approval of a new, larger plant operated by contract manufacturer Catalent Inc...

Premium

Healthcare

01 March, 2021

Steadview Capital makes partial exit from bulk drugs firm

Alternative investment firm Steadview Capital has made back-to-back partial exits from portfolio companies taking advantage of...

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News